{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:07:13Z","timestamp":1790737633424,"version":"4.1.0"},"reference-count":155,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Skin malignant melanoma is a highly aggressive skin tumor, which is also a major cause of skin cancer-related mortality. It can spread from a relatively small primary tumor and metastasize to multiple locations, including lymph nodes, lungs, liver, bone, and brain. What\u2019s more metastatic melanoma is the main cause of its high mortality. Among all organs, the lung is one of the most common distant metastatic sites of melanoma, and the mortality rate of melanoma lung metastasis is also very high. Elucidating the mechanisms involved in the pulmonary metastasis of cutaneous melanoma will not only help to provide possible explanations for its etiology and progression but may also help to provide potential new therapeutic targets for its treatment. Increasing evidence suggests that tumor-associated macrophages (TAMs) play an important regulatory role in the migration and metastasis of various malignant tumors. Tumor-targeted therapy, targeting tumor-associated macrophages is thus attracting attention, particularly for advanced tumors and metastatic tumors. However, the relevant role of tumor-associated macrophages in cutaneous melanoma lung metastasis is still unclear. This review will present an overview of the origin, classification, polarization, recruitment, regulation and targeting treatment of tumor-associated macrophages, as well as the soluble mediators involved in these processes and a summary of their possible role in lung metastasis from cutaneous malignant melanoma. This review particularly aims to provide insight into mechanisms and potential therapeutic targets to readers, interested in pulmonary metastasis melanoma.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1000927","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T06:25:38Z","timestamp":1662359138000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["The role of tumor-associated macrophages and soluble mediators in pulmonary metastatic melanoma"],"prefix":"10.3389","volume":"13","author":[{"given":"Kaifen","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Stoeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianglin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanze","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.09.075","article-title":"Melanoma: An update on systemic therapies","volume":"86","author":"Skudalski","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/pcmr.12172","article-title":"Why is melanoma so metastatic","volume":"27","author":"Braeuer","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5984","DOI":"10.3390\/cancers13235984","article-title":"Organ specific copy number variations in visceral metastases of human melanoma","volume":"13","author":"Papp","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejro.2019.08.001","article-title":"Two synchronous lung metastases from malignant melanoma: The same patient but different morphological patterns","volume":"6","author":"Borghesi","year":"2019","journal-title":"Eur J Radiol Open"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2004.03.002","article-title":"Chemokine receptors and melanoma metastasis","volume":"36","author":"Murakami","year":"2004","journal-title":"J Dermatol Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"Mmt58","DOI":"10.2217\/mmt-2021-0001","article-title":"Pulmonary metastatic melanoma: current state of diagnostic imaging and treatments","volume":"8","author":"Zhang","year":"2021","journal-title":"Melanoma Manag"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199710000-00010","article-title":"Primary melanoma of the lung: A clinicopathologic and immunohistochemical study of eight cases","volume":"21","author":"Wilson","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-015-9586-9","article-title":"The challenge of targeting metastasis","volume":"34","author":"Fidler","year":"2015","journal-title":"Cancer Metastasis Rev"},{"key":"B10","article-title":"Breast cancer metastasis","volume":"9","author":"Scully","year":"2012","journal-title":"Cancer Genomics Proteomics"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2011.12.001","article-title":"Differential macrophage programming in the tumor microenvironment","volume":"33","author":"Ruffell","year":"2012","journal-title":"Trends Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cas.12314","article-title":"Clinical significance of macrophage heterogeneity in human malignant tumors","volume":"105","author":"Komohara","year":"2014","journal-title":"Cancer Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.02.015","article-title":"Macrophages and therapeutic resistance in cancer","volume":"27","author":"Ruffell","year":"2015","journal-title":"Cancer Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"101938","DOI":"10.1016\/j.isci.2020.101938","article-title":"Prune-1 drives polarization of tumor-associated macrophages (TAMs) within the lung metastatic niche in triple-negative breast cancer","volume":"24","author":"Ferrucci","year":"2021","journal-title":"iScience"},{"key":"B15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","article-title":"Tumor-associated macrophages in tumor metastasis: Biological roles and clinical therapeutic applications","volume":"12","author":"Lin","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv474","article-title":"Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: Results from TRIBE and FIRE3 trials","volume":"26","author":"Sunakawa","year":"2015","journal-title":"Ann Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70122-X","article-title":"Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial","volume":"12","author":"Gnant","year":"2011","journal-title":"Lancet Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00078-4","article-title":"Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: A single-centre, open-label, dose-finding, non-randomised, phase 1b trial","volume":"17","author":"Nywening","year":"2016","journal-title":"Lancet Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13045-017-0430-2","article-title":"Tumor-associated macrophages: From basic research to clinical application","volume":"10","author":"Yang","year":"2017","journal-title":"J Hematol Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cmi.2014.83","article-title":"The origin and function of tumor-associated macrophages","volume":"12","author":"Liu","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/npjbcancer.2015.25","article-title":"Tumor-associated macrophages: Unwitting accomplices in breast cancer malignancy","volume":"2","author":"Williams","year":"2016","journal-title":"NPJ Breast Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"104119","DOI":"10.1016\/j.cellimm.2020.104119","article-title":"The roles of tumor-associated macrophages in tumor angiogenesis and metastasis","volume":"353","author":"Fu","year":"2020","journal-title":"Cell Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1126\/science.1252510","article-title":"The cellular and molecular origin of tumor-associated macrophages","volume":"344","author":"Franklin","year":"2014","journal-title":"Science"},{"key":"B27","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.immuni.2013.04.004","article-title":"Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes","volume":"38","author":"Hashimoto","year":"2013","journal-title":"Immunity"},{"key":"B28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.trecan.2015.11.004","article-title":"Ontogeny of tumor-associated macrophages and its implication in cancer regulation","volume":"2","author":"Franklin","year":"2016","journal-title":"Trends Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2613.2006.00478.x","article-title":"Tumour-associated macrophages and melanoma tumourigenesis: integrating the complexity","volume":"87","author":"Hussein","year":"2006","journal-title":"Int J Exp Pathol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-associated macrophages in tumor immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.788365","article-title":"Tumor associated macrophages: Origin, recruitment, phenotypic diversity, and targeting","volume":"11","author":"Hourani","year":"2021","journal-title":"Front Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901368","article-title":"CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages","volume":"184","author":"Gleissner","year":"2010","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1203017","article-title":"IL-17 stimulates differentiation of human anti-inflammatory macrophages and phagocytosis of apoptotic neutrophils in response to IL-10 and glucocorticoids","volume":"190","author":"Zizzo","year":"2013","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2015.02.004","article-title":"Macrophages and cancer: From mechanisms to therapeutic implications","volume":"36","author":"Ostuni","year":"2015","journal-title":"Trends Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40164-020-00171-5","article-title":"Macrophage, the potential key mediator in CAR-T related CRS","volume":"9","author":"Hao","year":"2020","journal-title":"Exp Hematol Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2012.4617","article-title":"Oxidative stress in malignant melanoma enhances tumor necrosis factor-\u03b1 secretion of tumor-associated macrophages that promote cancer cell invasion","volume":"19","author":"Lin","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1172\/JCI84427","article-title":"The impact of hypoxia on tumor-associated macrophages","volume":"126","author":"Henze","year":"2016","journal-title":"J Clin Invest"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2012.12.007","article-title":"Recruitment of monocytes\/macrophages in different tumor microenvironments","volume":"1835","author":"Lee","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-2310","article-title":"Cellular and molecular identity of tumor-associated macrophages in glioblastoma","volume":"77","author":"Chen","year":"2017","journal-title":"Cancer Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13578-019-0342-7","article-title":"Macrophages and hepatocellular carcinoma","volume":"9","author":"Tian","year":"2019","journal-title":"Cell Biosci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20180534","article-title":"Macrophages of distinct origins contribute to tumor development in the lung","volume":"215","author":"Loyher","year":"2018","journal-title":"J Exp Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-379214","article-title":"Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling","volume":"119","author":"Hume","year":"2012","journal-title":"Blood"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1084\/jem.193.6.727","article-title":"Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy","volume":"193","author":"Lin","year":"2001","journal-title":"J Exp Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24859","article-title":"Stromal cell-derived CSF-1 blockade prolongs xenograft survival of CSF-1-negative neuroblastoma","volume":"126","author":"Abraham","year":"2010","journal-title":"Int J Cancer"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700827","article-title":"Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft","volume":"127","author":"Gazzaniga","year":"2007","journal-title":"J Invest Dermatol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e1470729","DOI":"10.1080\/2162402X.2018.1470729","article-title":"Recruitment of CCR2(+) tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer","volume":"7","author":"Grossman","year":"2018","journal-title":"Oncoimmunology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.3390\/cancers12092718","article-title":"SFMBT2-mediated infiltration of preadipocytes and TAMs in prostate cancer","volume":"12","author":"Gwak","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1450715","article-title":"Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model","volume":"7","author":"Idorn","year":"2018","journal-title":"Oncoimmunology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302821","article-title":"CCL2 shapes macrophage polarization by GM-CSF and m-CSF: identification of CCL2\/CCR2-dependent gene expression profile","volume":"192","author":"Sierra-Filardi","year":"2014","journal-title":"J Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41419-019-1748-1","article-title":"Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment","volume":"10","author":"Chen","year":"2019","journal-title":"Cell Death Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12943-020-01165-x","article-title":"CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis","volume":"19","author":"Yang","year":"2020","journal-title":"Mol Cancer"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.886","article-title":"CCL2 as a potential therapeutic target for clear cell renal cell carcinoma","volume":"5","author":"Arakaki","year":"2016","journal-title":"Cancer Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.07.004","article-title":"Mitochondrial akt regulation of hypoxic tumor reprogramming","volume":"30","author":"Chae","year":"2016","journal-title":"Cancer Cell"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-2104","article-title":"Hypoxia induces escape from innate immunity in cancer cells via increased expression of ADAM10: Role of nitric oxide","volume":"71","author":"Barsoum","year":"2011","journal-title":"Cancer Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1634\/theoncologist.9-90005-4","article-title":"Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response","author":"Vaupel","year":"2004","journal-title":"Oncologist"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30420","article-title":"M2 macrophage accumulation contributes to pulmonary fibrosis, vascular dilatation, and hypoxemia in rat hepatopulmonary syndrome","volume":"236","author":"Chen","year":"2021","journal-title":"J Cell Physiol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103226","article-title":"Dexmedetomidine inhibits LPS-induced proinflammatory responses via suppressing HIF1\u03b1-dependent glycolysis in macrophages","volume":"12","author":"Meng","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0198","article-title":"CCL20 expression by tumor-associated macrophages predicts progression of human primary cutaneous melanoma","volume":"6","author":"Samaniego","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1615\/CritRevOncog.v18.i1-2.40","article-title":"On the origin of cancer metastasis","volume":"18","author":"Seyfried","year":"2013","journal-title":"Crit Rev Oncog"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2021.11.008","article-title":"Epigenetic basis and targeting of cancer metastasis","volume":"8","author":"Banerjee","year":"2022","journal-title":"Trends Cancer"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0b013e3283632cbe","article-title":"Pulmonary metastasectomy for malignant melanoma: Prognostic factors for long-term survival","volume":"23","author":"Younes","year":"2013","journal-title":"Melanoma Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ejro.2019.02.003","article-title":"The clinical significance of indeterminate pulmonary nodules in melanoma patients at baseline and during follow-up chest CT","volume":"6","author":"Soliman","year":"2019","journal-title":"Eur J Radiol Open"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2018.12.001","article-title":"EMT transition states during tumor progression and metastasis","volume":"29","author":"Pastushenko","year":"2019","journal-title":"Trends Cell Biol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2014.2761","article-title":"Macrophage-secreted IL-8 induces epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2\/STAT3\/Snail pathway","volume":"46","author":"Fu","year":"2015","journal-title":"Int J Oncol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/mc.22451","article-title":"Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway","volume":"55","author":"Ravi","year":"2016","journal-title":"Mol Carcinog"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.03.021","article-title":"A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis","volume":"25","author":"Su","year":"2014","journal-title":"Cancer Cell"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq292","article-title":"The epithelial-mesenchymal transition (EMT) phenomenon","author":"Savagner","year":"2010","journal-title":"Ann Oncol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1093\/jb\/mvr136","article-title":"TGF-\u03b2-induced epithelial-mesenchymal transition of A549 lung adenocarcinoma cells is enhanced by pro-inflammatory cytokines derived from RAW 264.7 macrophage cells","volume":"151","author":"Kawata","year":"2012","journal-title":"J Biochem"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.9919","article-title":"Macrophage markers in serum and tumor have prognostic impact in American joint committee on cancer stage I\/II melanoma","volume":"27","author":"Jensen","year":"2009","journal-title":"J Clin Oncol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-200510000-00010","article-title":"Tumour-associated macrophage infiltration, neovascularization and aggressiveness in malignant melanoma: Role of monocyte chemotactic protein-1 and vascular endothelial growth factor-a","volume":"15","author":"Varney","year":"2005","journal-title":"Melanoma Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10456-017-9552-y","article-title":"Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy","volume":"20","author":"Ramjiawan","year":"2017","journal-title":"Angiogenesis"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-1278","article-title":"Macrophages regulate the angiogenic switch in a mouse model of breast cancer","volume":"66","author":"Lin","year":"2006","journal-title":"Cancer Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-0912","article-title":"Tumor-associated macrophages press the angiogenic switch in breast cancer","volume":"67","author":"Lin","year":"2007","journal-title":"Cancer Res"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200422087","article-title":"An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis","volume":"114","author":"Giraudo","year":"2004","journal-title":"J Clin Invest"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.09.083","article-title":"Macrophage-induced lymphangiogenesis and metastasis following paclitaxel chemotherapy is regulated by VEGFR3","volume":"17","author":"Alishekevitz","year":"2016","journal-title":"Cell Rep"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00075","article-title":"Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis","volume":"5","author":"Riabov","year":"2014","journal-title":"Front Physiol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-1354","article-title":"Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner","volume":"17","author":"Chen","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-019-00545-7","article-title":"Monocyte chemoattractant protein-1 (MCP-1\/CCL2) drives activation of bone remodelling and skeletal metastasis","volume":"17","author":"Mulholland","year":"2019","journal-title":"Curr Osteoporos Rep"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.030403","article-title":"Mouse models of metastasis: Progress and prospects","volume":"10","author":"G\u00f3mez-Cuadrado","year":"2017","journal-title":"Dis Model Mech"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1007\/s10911-006-9021-5","article-title":"Probing the microenvironment of mammary tumors using multiphoton microscopy","volume":"11","author":"Sidani","year":"2006","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-2819","article-title":"Novel mechanism of macrophage-mediated metastasis revealed in a zebrafish model of tumor development","volume":"75","author":"Wang","year":"2015","journal-title":"Cancer Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.02.006","article-title":"CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3","volume":"19","author":"Chen","year":"2011","journal-title":"Cancer Cell"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2018.1526602","article-title":"The long non-coding RNA CRNDE competed endogenously with miR-205 to promote proliferation and metastasis of melanoma cells by targeting CCL18","volume":"17","author":"Xu","year":"2018","journal-title":"Cell Cycle"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.05.008","article-title":"Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor","volume":"24","author":"Schumacher","year":"2013","journal-title":"Cancer Cell"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-376426","article-title":"Recruitment of monocytes\/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice","volume":"119","author":"Gil-Bernab\u00e9","year":"2012","journal-title":"Blood"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006562","article-title":"A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth","volume":"4","author":"Qian","year":"2009","journal-title":"PloS One"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.09.011","article-title":"Characteristics and significance of the pre-metastatic niche","volume":"30","author":"Liu","year":"2016","journal-title":"Cancer Cell"},{"key":"B91","doi-asserted-by":"publisher","first-page":"103416","DOI":"10.1016\/j.critrevonc.2021.103416","article-title":"Bone marrow\/bone pre-metastatic niche for breast cancer cells colonization: The role of mesenchymal stromal cells","volume":"164","author":"Sanmartin","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13046-020-01816-3","article-title":"Exosomal ANGPTL1 attenuates colorectal cancer liver metastasis by regulating kupffer cell secretion pattern and impeding MMP9 induced vascular leakiness","volume":"40","author":"Jiang","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-013-9420-1","article-title":"The pre-metastatic niche: Finding common ground","volume":"32","author":"Sceneay","year":"2013","journal-title":"Cancer Metastasis Rev"},{"key":"B94","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s40425-019-0817-4","article-title":"Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth","volume":"7","author":"Cao","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B95","doi-asserted-by":"publisher","first-page":"12","DOI":"10.20517\/2394-5079.2020.83","article-title":"Epigenetic mechanisms in hepatitis b virus-associated hepatocellular carcinoma","volume":"7","author":"Andrisani","year":"2021","journal-title":"Hepatoma Res"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201141792","article-title":"Epigenetic control of macrophage polarization","volume":"41","author":"Takeuch","year":"2011","journal-title":"Eur J Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2021.09.001","article-title":"Epigenetic regulation of immunosuppressive tumor-associated macrophages through dysregulated microRNAs","volume":"124","author":"Ahmad","year":"2022","journal-title":"Semin Cell Dev Biol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0000000000000109","article-title":"Macrophage polarization: The epigenetic point of view","volume":"25","author":"Van den Bossche","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24556","article-title":"Epigenetic control of macrophage polarization: Implications for targeting tumor-associated macrophages","volume":"9","author":"de Groot","year":"2018","journal-title":"Oncotarget"},{"key":"B100","doi-asserted-by":"publisher","first-page":"10701","DOI":"10.3390\/ijms221910701","article-title":"Chronic and cycling hypoxia: Drivers of cancer chronic inflammation through HIF-1 and NF-\u03baB activation: A review of the molecular mechanisms","volume":"22","author":"Korbecki","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B101","article-title":"Tumor-associated macrophages: Function, phenotype, and link to prognosis in human lung cancer","volume":"4","author":"Quatromoni","year":"2012","journal-title":"Am J Transl Res"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000543","article-title":"TFEB is a master regulator of tumor-associated macrophages in breast cancer","volume":"8","author":"Li","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-3360","article-title":"Pharmacologic activation of LXR alters the expression profile of tumor-associated macrophages and the abundance of regulatory T cells in the tumor microenvironment","volume":"81","author":"Carb\u00f3","year":"2021","journal-title":"Cancer Res"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1172\/JCI131335","article-title":"Transcription factor c-maf is a checkpoint that programs macrophages in lung cancer","volume":"130","author":"Liu","year":"2020","journal-title":"J Clin Invest"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.21037\/atm-20-2037","article-title":"Metabolic reprograming of tumor-associated macrophages","volume":"8","author":"Puthenveetil","year":"2020","journal-title":"Ann Transl Med"},{"key":"B106","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1158\/0008-5472.CAN-13-1196","article-title":"Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population","volume":"74","author":"Laoui","year":"2014","journal-title":"Cancer Res"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.09.008","article-title":"Macrophage metabolism controls tumor blood vessel morphogenesis and metastasis","volume":"24","author":"Wenes","year":"2016","journal-title":"Cell Metab"},{"key":"B108","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12943-019-0982-6","article-title":"Exosome-orchestrated hypoxic tumor microenvironment","volume":"18","author":"Meng","year":"2019","journal-title":"Mol Cancer"},{"key":"B109","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.canlet.2018.08.001","article-title":"Exosomes derived from hypoxic epithelial ovarian cancer cells deliver microRNAs to macrophages and elicit a tumor-promoted phenotype","volume":"435","author":"Chen","year":"2018","journal-title":"Cancer Lett"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.356","article-title":"TAMeless traitors: macrophages in cancer progression and metastasis","volume":"117","author":"Aras","year":"2017","journal-title":"Br J Cancer"},{"key":"B111","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11912-017-0634-1","article-title":"CSF-1R inhibitor development: Current clinical status","volume":"19","author":"Peyraud","year":"2017","journal-title":"Curr Oncol Rep"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-16-0866","article-title":"Colony-stimulating factor 1 receptor blockade inhibits tumor growth by altering the polarization of tumor-associated macrophages in hepatocellular carcinoma","volume":"16","author":"Ao","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0961","article-title":"Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice","volume":"64","author":"Aharinejad","year":"2004","journal-title":"Cancer Res"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411366","article-title":"Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor","volume":"373","author":"Tap","year":"2015","journal-title":"N Engl J Med"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25191","article-title":"Targeting of colony-stimulating factor 1 receptor (CSF1R) in the CLL microenvironment yields antineoplastic activity in primary patient samples","volume":"9","author":"Edwards","year":"2018","journal-title":"Oncotarget"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.05.016","article-title":"Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy","volume":"25","author":"Ries","year":"2014","journal-title":"Cancer Cell"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan3311","article-title":"T Cell-induced CSF1 promotes melanoma resistance to PD1 blockade","volume":"10","author":"Neubert","year":"2018","journal-title":"Sci Transl Med"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-012-9869-8","article-title":"Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer","volume":"31","author":"Pienta","year":"2013","journal-title":"Invest New Drugs"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-019-00830-3","article-title":"Phase 1b study of a small molecule antagonist of human chemokine (C-c motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel\/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma","volume":"38","author":"Noel","year":"2020","journal-title":"Invest New Drugs"},{"key":"B120","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s42003-020-01441-y","article-title":"Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy","volume":"3","author":"Tu","year":"2020","journal-title":"Commun Biol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40164-022-00258-1","article-title":"Correction to: Roles of tumor-associated macrophages in tumor progression: Implications on therapeutic strategies","volume":"11","author":"Zhu","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40164-021-00252-z","article-title":"Roles of tumor-associated macrophages in tumor progression: Implications on therapeutic strategies","volume":"10","author":"Zhu","year":"2021","journal-title":"Exp Hematol Oncol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-med-062518-045435","article-title":"CD40 agonist antibodies in cancer immunotherapy","volume":"71","author":"Vonderheide","year":"2020","journal-title":"Annu Rev Med"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0258","article-title":"Combination of CD40 agonism and CSF-1R blockade reconditions tumor-associated macrophages and drives potent antitumor immunity","volume":"5","author":"Wiehagen","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-0903","article-title":"A phase I study of APX005M and cabiralizumab with or without nivolumab in patients with melanoma, kidney cancer, or non-small cell lung cancer resistant to anti-PD-1\/PD-L1","volume":"27","author":"Weiss","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2019.02.003","article-title":"Targeting tumor-associated macrophages in cancer","volume":"40","author":"Pathria","year":"2019","journal-title":"Trends Immunol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.12.037","article-title":"A novel liposomal clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects","volume":"223","author":"Piaggio","year":"2016","journal-title":"J Control Release"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8021","article-title":"Macrophages in skin melanoma-the key element in melanomagenesis","volume":"15","author":"Pieniazek","year":"2018","journal-title":"Oncol Lett"},{"key":"B129","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ctrv.2019.05.003","article-title":"Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody","volume":"76","author":"von Moos","year":"2019","journal-title":"Cancer Treat Rev"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202781","article-title":"Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma model","volume":"190","author":"Sevko","year":"2013","journal-title":"J Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1177\/154405910708601102","article-title":"Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates","volume":"86","author":"Kimmel","year":"2007","journal-title":"J Dent Res"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e32833ad677","article-title":"Bisphosphonate adverse effects, lessons from large databases","volume":"22","author":"Abrahamsen","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.9b00261","article-title":"Targeted delivery of zoledronate to tumor-associated macrophages for cancer immunotherapy","volume":"16","author":"Zang","year":"2019","journal-title":"Mol Pharm"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.8b16588","article-title":"Zoledronic acid-containing nanoparticles with minimum premature release show enhanced activity against extraskeletal tumor","volume":"11","author":"Li","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-2731","article-title":"Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses","volume":"73","author":"Mitchem","year":"2013","journal-title":"Cancer Res"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.4734","article-title":"Efficacy and safety of trabectedin or dacarbazine for metastatic liposarcoma or leiomyosarcoma after failure of conventional chemotherapy: Results of a phase III randomized multicenter clinical trial","volume":"34","author":"Demetri","year":"2016","journal-title":"J Clin Oncol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax6337","article-title":"Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses","volume":"12","author":"Jaynes","year":"2020","journal-title":"Sci Transl Med"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.247","article-title":"Immunomodulation by imiquimod in patients with high-risk primary melanoma","volume":"132","author":"Narayan","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.9b00631","article-title":"Small-molecule modulators of toll-like receptors","volume":"53","author":"Wang","year":"2020","journal-title":"Acc Chem Res"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.11.011","article-title":"Sorafenib inhibits macrophage-induced growth of hepatoma cells by interference with insulin-like growth factor-1 secretion","volume":"62","author":"Sprinzl","year":"2015","journal-title":"J Hepatol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-3480","article-title":"Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1 profile in a TLR4-dependent manner","volume":"78","author":"Wanderley","year":"2018","journal-title":"Cancer Res"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1047584","article-title":"Immunomodulatory effect of peritumorally administered interferon-beta on melanoma through tumor-associated macrophages","volume":"4","author":"Kakizaki","year":"2015","journal-title":"Oncoimmunology"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2011.02.002","article-title":"A synthetic NOD2 agonist, muramyl dipeptide (MDP)-lys (L18) and IFN-\u03b2 synergistically induce dendritic cell maturation with augmented IL-12 production and suppress melanoma growth","volume":"62","author":"Fujimura","year":"2011","journal-title":"J\u00a0Dermatol Sci"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31545","article-title":"Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer","volume":"143","author":"La Fleur","year":"2018","journal-title":"Int J Cancer"},{"key":"B145","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"B146","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.3390\/cancers12113401","article-title":"Targeting tumor-associated macrophages to increase the efficacy of immune checkpoint inhibitors: A glimpse into novel therapeutic approaches for metastatic melanoma","volume":"12","author":"Ceci","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"B148","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40164-019-0150-0","article-title":"The efficacy and safety of combination of PD-1 and CTLA-4 inhibitors: A meta-analysis","volume":"8","author":"Wu","year":"2019","journal-title":"Exp Hematol Oncol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1038\/nature22396","article-title":"PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity","volume":"545","author":"Gordon","year":"2017","journal-title":"Nature"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002057","article-title":"Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma","volume":"9","author":"Zakharia","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-2812","article-title":"MFG-E8 drives melanoma growth by stimulating mesenchymal stromal cell-induced angiogenesis and M2 polarization of tumor-associated macrophages","volume":"76","author":"Yamada","year":"2016","journal-title":"Cancer Res"},{"key":"B152","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.biomaterials.2016.01.064","article-title":"Carboxyl- and amino-functionalized polystyrene nanoparticles differentially affect the polarization profile of M1 and M2 macrophage subsets","volume":"85","author":"Fuchs","year":"2016","journal-title":"Biomaterials"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1039\/D1CC02678J","article-title":"Polymer nanoparticles regulate macrophage repolarization for antitumor treatment","volume":"57","author":"Fu","year":"2021","journal-title":"Chem Commun (Camb)"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.5b06779","article-title":"Bioconjugated manganese dioxide nanoparticles enhance chemotherapy response by priming tumor-associated macrophages toward M1-like phenotype and attenuating tumor hypoxia","volume":"10","author":"Song","year":"2016","journal-title":"ACS Nano"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.7b05465","article-title":"Molecular-targeted immunotherapeutic strategy for melanoma via dual-targeting nanoparticles delivering small interfering RNA to tumor-associated macrophages","volume":"11","author":"Qian","year":"2017","journal-title":"ACS Nano"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1000927\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T06:25:42Z","timestamp":1662359142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1000927\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":155,"alternative-id":["10.3389\/fimmu.2022.1000927"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1000927","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]},"article-number":"1000927"}}